These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34345219)

  • 1. Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy.
    Chen J; Li S; Lei Z; Tang Q; Mo L; Zhao X; Xie F; Zi D; Tan J
    Int J Biol Sci; 2021; 17(11):2957-2969. PubMed ID: 34345219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.
    Maas MN; Hintzen JCJ; Löffler PMG; Mecinović J
    Chem Commun (Camb); 2021 Apr; 57(26):3283-3286. PubMed ID: 33651072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
    Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
    Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD-ACE2 Interaction.
    Fernandez-Fuentes N; Molina R; Oliva B
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2.
    Wei S; Duan S; Liu X; Wang H; Ding S; Chen Y; Xie J; Tian J; Yu N; Ge P; Zhang X; Chen X; Li Y; Meng Q
    Int Immunopharmacol; 2021 Jan; 90():107172. PubMed ID: 33191178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
    Zhou Y; Wang M; Li Y; Wang P; Zhao P; Yang Z; Wang S; Zhang L; Li Z; Jia K; Zhong C; Li N; Yu Y; Hou J
    Immunol Lett; 2021 Sep; 237():33-41. PubMed ID: 34228987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.
    Ferrari M; Mekkaoui L; Ilca FT; Akbar Z; Bughda R; Lamb K; Ward K; Parekh F; Karattil R; Allen C; Wu P; Baldan V; Mattiuzzo G; Bentley EM; Takeuchi Y; Sillibourne J; Datta P; Kinna A; Pule M; Onuoha SC
    J Virol; 2021 Sep; 95(19):e0068521. PubMed ID: 34287040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection.
    Liu S; Chen H; Chen X; Luo N; Peraramelli S; Gong X; Zhang MJ; Ou L
    Front Immunol; 2024; 15():1365803. PubMed ID: 38646520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Natural Bioactive Peptide from
    Wang Y; Wang Q; Chen X; Li B; Zhang Z; Yao L; Liu X; Zhang R
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
    J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
    Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
    Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function analysis of a potent human neutralizing antibody CA521
    Song D; Wang W; Dong C; Ning Z; Liu X; Liu C; Du G; Sha C; Wang K; Lu J; Sun B; Zhao Y; Wang Q; Xu H; Li Y; Shen Z; Jiao J; Wang R; Tian J; Liu W; Wang L; Deng YQ; Dou C
    Commun Biol; 2021 Apr; 4(1):500. PubMed ID: 33893388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus.
    Yeh H; Vo DNK; Lin ZH; Ho HPT; Hua WJ; Qiu WL; Tsai MH; Lin TY
    Phytomedicine; 2022 Aug; 103():154215. PubMed ID: 35691077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.
    Hou Y; Ge S; Li X; Wang C; He H; He L
    Chem Biol Interact; 2021 Apr; 338():109420. PubMed ID: 33609497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.
    Mehdipour AR; Hummer G
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33903171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
    Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
    PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.